Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.04/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Basic and diluted loss per share (Note 2): -0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic and diluted loss per share (Note 2): -0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q2 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- InspireMD (NSPR) Tops Q2 EPS by 1c
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
